Orenitram (treprostinil) Extended Release Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
January 2016
ADVERSE REACTIONS
Clinical Trials Experience
…The safety of Orenitram was also evaluated in an open-label...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Clinical Trials | Drugs & Pharmacology